IP Library Granted Patent US 8,067,027
Granted Patent B2
US 8,067,027 · App. 12/648,522 · Granted Nov 29, 2011

Tissue augmentation material and method

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,067,027
App. No.
12/648,522
Granted
Nov 29, 2011
Kind
B2
Abstract

A material and method for augmenting soft tissue. The tissue augmentation material consists essentially of water and a polysaccharide gel former selected from the group consisting of a cellulose polysaccharide, starch, chitin, chitosan, hyaluronic acid, hydrophobe modified polysaccharide, an alginate, a carrageenan, agar, agarose, an intramolecular complex of a polysaccharide, an oligosaccharide and a macrocylic polysaccharide. Glycerin may also be included. The material may be used to augment soft tissue in a variety of areas, including the facial region and vocal folds.

Claims (9)

1. An injectable tissue augmentation solution for augmenting soft tissue with adjusted viscosity and elasticity for a specific tissue application, consisting essentially of: (1) water; and (2) a water soluble polysaccharide gel former selected from the group consisting of (i) nonionic polysaccharides, (ii) anionic polysaccharides, and (iii) cationic polysaccharides and combinations thereof, whereby the augmentation solution of the water and the polysaccharide gel has its viscosity and elasticity adjusted for injection into a soft tissue site.

2. The injectable tissue augmentation solution of claim 1 , wherein the polysaccharide gel former comprises sodium carboxymethylcellulose.

3. The injectable tissue augmentation solution of claim 1 , further including glycerin.

4. The injectable tissue augmentation solution of claim 2 , wherein the augmentation solution further has an elastic modulus, under a 100 Pa maximum force at 1 hertz, of 50 to 1000 Pa.

5. The injectable tissue augmentation solution of claim 4 , wherein the solution further has a ratio of viscous modulus to elastic modulus of 0.2 to 1.0, when measured under a 100 Pa maximum force at 1 hertz.

6. The injectable tissue augmentation solution of claim 5 , wherein the solution further has a recovery of deformation of 5 to 75% after being subjected to a deformation force of 100 Pa for 120 seconds.

7. The injectable tissue augmentation solution of claim 6 , wherein the majority of the recovery of the deformation occurs in 2 to 10 seconds.

8. The injectable tissue augmentation solution of claim 1 , wherein the polysaccharide gel former is agar methylcellulose, hydroxypropyl methylcellulose, chitosan, sodium alginate, or xanthan gum.

9. The injectable tissue augmentation solution of claim 2 , wherein the solution has a viscosity of between 1 and 5 million centipoise when stressed with a shear of 200 Pa and a viscosity of 300,000 to 1 million centipoise when stressed with a shear of 500 Pa.

Assignments (3)
CHANGE OF NAME Recorded Sep 1, 2010
From: BIOFORM MEDICAL, INC.
To: MERZ AESTHETICS, INC.
Reel/Frame 024925/0633 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Dec 30, 2009
From: HUBBARD, WILLIAM G.
To: BIOFORM, INC.
Reel/Frame 023719/0138 →
CHANGE OF NAME Recorded Dec 30, 2009
From: BIOFORM, INC.
To: BIOFORM MEDICAL, INC.
Reel/Frame 023719/0913 →